Using NGS to identify novel biomarkers in cancer, inflammatory and neuro degenerative diseases

Olink Seminar: Using NextGen Sequencing to identify novel biomarkers in cancer, inflammatory and neuro degenerative diseases
Olink Proteomics high throughput technology enables researchers to accurately measure over 3,000 proteins in less than 80ul of sample. This seminar will provide a short technology overview and highlight how these assays are being used to leverage new discoveries in biomarker research, patient stratification, and drug target research.
September 22nd
biotech.ufl.ed...